HCID 178452121、化合物 → HCID 178452119、化合物

HRID 132040

反応式

HRID 132040 の反応式
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([NH:14][C:15]([C:17]2[C:21]([N+:22]([O-])=O)=[CH:20][NH:19][N:18]=2)=[O:16])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]>C(O)C.CN(C=O)C.[Pd]>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([NH:14][C:15]([C:17]2[C:21]([NH2:22])=[CH:20][NH:19][N:18]=2)=[O:16])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:2])[CH3:3]

参加物

4

反応物 1

HCID 178452121HCID 178452121、化合物

生成物 1

HCID 178452119HCID 178452119、化合物収率 73.8%

試薬・触媒・溶媒 2

HCID 23938Palladium触媒HCID 19794673N,N-dimethylformamide ethanol溶媒

実験手順

4-[(4-Nitro-1H-pyrazole-3-carbonyl)-amino]-piperidine-1-carboxylic acid tert-butyl ester (13.05 g) was dissolved in ethanol/DMF (300 ml/75 ml), treated with 10% palladium on carbon (500 mg) then hydrogenated at room temperature and pressure overnight. The catalyst was removed by filtration through Celite and the filtrate evaporated and re-evaporated with toluene. The crude material was purified by flash column chromatography eluting with EtOAc then 2% MeOH/EtOAc then 5% MeOH/EtOAc. Product containing fractions were combined and evaporated to give 8.78 g of 4-[(4-amino-1H-pyrazole-3-carbonyl)-amino]-piperidine-1-carboxylic acid tert-butyl ester as a brown foam. (LC/MS: Rt 1.91, [M+H]+310).

後処理

  1. customthen hydrogenated at room temperature
  2. custompressure overnight
  3. customThe catalyst was removed by filtration through Celite
  4. customthe filtrate evaporated
  5. customre-evaporated with toluene
  6. customThe crude material was purified by flash column chromatography
  7. washeluting with EtOAc
  8. additionProduct containing fractions
  9. customevaporated

出典と根拠

ORDレコード
ord-5f187cca0bfa4cf3acfcedc2cfe250c6
出典データセット
uspto-grants-2008_06
特許番号
US07385059B2

関連ノート

読み込み中…